MRI-Guided SBRT Cuts Long-Term Toxicities in Prostate Cancer
TOPLINE:Aggressive margin decrease with MRI-guided stereotactic body radiotherapy (SBRT) resulted in a considerably lower occurrence of late genitourinary and intestinal toxicities at 2 years compared to CT-guided SBRT in males with localized prostate cancer, brand-new information revealed.METHOD:MRI-guided SBRT is understood to decrease preparing margins in prostate cancer and result in less intense toxicity compared to basic CT-guided SBRT. The long-lasting advantages of the MRI-guided technique stay uncertain.To learn, scientists performed the stage 3 MIRAGE trial, in which 156 clients with localized prostate cancer were arbitrarily designated to get either MRI-guided SBRT with 2-mm margins or CT-guided SBRT with 4-mm margins.The MIRAGE trial at first reported the main result of intens...